Skip to main content
Caplight Logo









inCerebro

inCerebro

Private
SeoulHealthcare & Life Scienceshttps://incerebro.com/incerebro

Last Round

Seed

Jul 13, 2021

Total Funding Raised

$4.36M

Company Overview

inCerebro operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Seed round in July 2021.

inCerebro is a biotechnology company that develops a computational drug discovery platform combining artificial intelligence with physics-based methods and quantum mechanical calculations.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

inCerebro Comparables

Compare inCerebro with similar companies based on industry and business-model similarity.

inCerebro comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Innovo Therapeutics
85%
Qubit Pharmaceuticals
84%
PharmCADD Co., Ltd.
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

inCerebro Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 13, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

inCerebro Investors

Notable investors and investment history

inCerebro investors
InvestorRounds
Timefolio Asset ManagementSeed
Albatross InvestmentSeed
HB InvestmentSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 13, 2021

    $4.36M round led by HB Investment

Book a demo to see all signals

For institutional investors. Book with your work email.

inCerebro Filings

Explore SEC and related filing metadata, where available.

inCerebro filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about inCerebro's valuation, stock price, and market status.

Is inCerebro a public or private company?

inCerebro is a private company.

What is the current stock price of inCerebro?

inCerebro is a private company, so its shares have no public market price. Caplight tracks inCerebro's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is inCerebro worth (valuation)?

Valuation information for inCerebro is not publicly available.

Can I buy inCerebro stock?

inCerebro shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was inCerebro's last funding round?

inCerebro's most recent funding round was Seed on July 13, 2021.

Who are the main investors in inCerebro?

Key investors in inCerebro include HB Investment.

Will inCerebro IPO soon?

No public IPO plans have been announced for inCerebro.

How can I track inCerebro secondary market activity?

Caplight tracks bids, offers, and trades in inCerebro's shares on secondary markets.

Firmographic Details

HeadquartersSeoul
Employee Range1
Year Founded2019
Last FundingJul 13, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?